FEBS Journal

Cover image for Vol. 282 Issue 17

Edited By: Seamus Martin

Impact Factor: 4.001

ISI Journal Citation Reports © Ranking: 2014: 77/289 (Biochemistry & Molecular Biology)

Online ISSN: 1742-4658

New Members of the Editorial Board

New members of The FEBS Journal Editorial Board

We are very pleased to welcome five new members of the Editorial Board:

Andrey Abramov, London; Michael Boutros, Heidelberg; Eleonora Candi, Rome; Kevin Ryan, Glasgow, Commissioning Editor; and Andreas Villunger, Innsbruck


Andrey Y. Abramov, London
Department of Molecular Neuroscience, Institute of Neurology, University College London, London

Professor Andrey Abramov obtained his PhD at the Department of Biophysics, Tashkent State University, Uzbekistan, for work on the role of biologically active substances isolated from plants on calcium homeostasis and mitochondrial metabolism in mammalian cells. His research in the Department of Physiology at University College London as a Postdoctoral Research Fellow explored the role of mitochondria, calcium and reactive oxygen species in physiology and pathology. He was recruited to the Department of Molecular Neuroscience, UCL Institute of Neurology in 2008 to initiate and lead the cell physiology laboratory.


Michael Boutros, Heidelberg
German Cancer Research Center and Heidelberg University

Michael Boutros is a Head of Division at the German Cancer Research Center (DKFZ) and Professor at Heidelberg University. His research interests are in systems genetics, in particular in relation to cellular signaling in developmental biology and cancer. His group uses large-scale functional approaches to dissect genotype to phenotype relationships. Michael received his Ph.D. working at EMBL and then did his postdoctoral research at Harvard Medical School. He is a member of the European Molecular Biology Organisation (EMBO).


Eleonora Candi, Rome
Dept. Experimental Medicine & Surgery, University of Tor Vergata

Dr Eleonora Candi received her Doctoral degree in Biology (1991) and her PhD (1995) from the University of Rome “Tor Vergata”, Italy, before becoming Associate Professor in Molecular Biology at the Faculty of Medicine at the University of Rome “Tor Vergata”. She did her pre- and post-doctoral training, from 1993–1998, at the Skin Biology Branch, NIAMS, National Institute of Health, Bethesda, MD, USA, working on transglutaminases and their substrates. She has been working on cell death, both apoptosis and cornification, for the past 18 years. Her current scientific interest is the role of p63, homolog of p53, in epithelia development and tumour formation.


Kevin Ryan, Glasgow (Commissioning Editor)
Tumour Cell Death Laboratory, The Beatson Institute for Cancer Research

Professor Kevin Ryan obtained his BSc in Biochemistry from the University of Liverpool, and was awarded a PhD by the University of Glasgow for work at the Beatson Institute for Cancer Research.  Following post-doctoral work at the US National Cancer Institute at Frederick, Maryland, he was granted a Cancer Research UK Senior Cancer Research Fellowship and returned to the Beatson to establish his own research group.  In 2007, he was appointed Professor of Molecular Cell Biology at the University of Glasgow. He has been awarded the European Association for Cancer Research (EACR) ‘Cancer Researcher Award’ and the Tenovus Medal.  Kevin’s studies focus on the identification of cell death regulators involved in tumour development and tumour therapy, with particular focus on how the apoptotic and autophagic pathways integrate to determine cell fate.


Andreas Villunger, Innsbruck
Division of Developmental Immunology, Biocenter, Medical University of Innsbruck

Professor Andreas Villunger conducted his undergraduate studies in Biology in Salzburg and Innsbruck, Austria, and obtained his Master and PhD degrees for research on cytokine signalling in multiple myeloma. After post-doctoral work in the Ras/PKC signalling field, Andreas moved to the Walter and Eliza Hall Institute, Melbourne, Australia, to conduct research on the role of Bcl-2 family proteins in lymphocyte development and transformation. After his return to Austria in 2003, he continued to work on Bcl-2 family proteins in the immune system and started to explore the role of caspases in tumor suppression. He has been awarded the prestigious START Prize by the Austrian Science Fund and the Novartis Prize for Medical Research. In 2009, he was appointed full professor at the Medical University Innsbruck and is head of the Division of Developmental Immunology.